Staged unilateral versus bilateral subthalamic nucleus stimulator implantation in Parkinson disease

Movement Disorders

Volumn 22, Issue 10, 2007, Pages 1476-1481

  Samii, Ali ^a,b,d   Kelly, Valerie E ^c   Slimp, Jefferson C ^c   Shumway Cook, Anne ^c   Goodkin, Robert ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d NONE   (United States)

Author keywords

Deep brain stimulation; Dyskinesia; Parkinson disease; Staged surgery; Subthalamic nucleus

Indexed keywords

LEVODOPA; PRAMIPEXOLE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DRUG DOSE REDUCTION; DYSKINESIA; ELECTRODE; ELECTROSTIMULATION THERAPY; FEMALE; HUMAN; IMPLANTATION; MALE; MOTOR ACTIVITY; PARKINSON DISEASE; PRIORITY JOURNAL; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME; UNIFIED PARKINSON DISEASE RATING SCALE;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; DISABILITY EVALUATION; ELECTRIC STIMULATION; ELECTRIC STIMULATION THERAPY; ELECTRODES, IMPLANTED; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; SUBTHALAMIC NUCLEUS;

EID: 34548041194     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21554     Document Type: Article

References (13)

1. Samii A, Nutt JG, Ransom BR. Parkinson's disease. Lancet 2004;363:1783-1793.
2. Deep-Brain Stimulation for Parkinson's Disease Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001;345:956-963.
3. Schuurman PR, Bosch DA, Bossuyt PM, et al. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med 2000;342:461-468.
4. Moro E, Scerrati M, Romito LM, Roselli R, Tonali P, Albanese A. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease. Neurology 1999;53:85-90.
5. Germano IM, Gracies JM, Weisz DJ, Tse W, Roller WC, Olanow CW. Unilateral stimulation of the subthalamic nucleus in Parkinson disease: a double-blind 12-month evaluation study. J Neurosurg 2004;101:36-42.
6. Kumar R, Lozano AM, Sime E, Halket E, Lang AE. Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation. Neurology 1999;53:561-566.
7. Limousin P, Pollak P, Benazzouz A, et al. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 1995;345:91-95.
8. Nagel A, Gracia LM, Gomez JB, Martinez-Sarries J, Bermejo F. Unified Parkinson's disease rating scale characteristics and structure. The Cooperative Multicentric Group. Mov Disord 1994;9:76-83.
9. Goetz CG, Stebbins GT, Shale HM, et al. Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment. Mov Disord 1994;9:390-394.
10. Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003;349:1925-1934.
11. Bastian AJ, Kelly VE, Revilla FJ, Perlmutter JS, Mink JW. Different effects of unilateral versus bilateral subthalamic nucleus stimulation on walking and reaching in Parkinson's disease. Mov Disord 2003;18:1000-1007.
12. Schrag A, Sampaio C, Counsell N, Poewe N. Minimal Clinically important change on the unified Parkinson's disease rating scale. Mov Disord 2006;21:1200-1207.
13. Charles PD, Van Blercom N, Krack P, et al. Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology 2002;59:932-934.